14 results  1 of 1 

1 Antiemetic Prophylaxis with Ramosetron for Postoperative Nausea and Vomiting in Patients Undergoing Microvascular Decompression : A Prospective, Randomized Controlled Trial
Chang-Hoon Koo, So Young Ji, Yu Kyung Bae, Young-Tae Jeon, Jung-Hee Ryu, Jung Ho Han
J Korean Neurosurg Soc.2022;65(6):853-860.   Published online 2022 April 18     DOI: http://dx.doi.org/10.3340/jkns.2021.0288
      
2 Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
Jin Hyoung Kang, Jung Hye Kwon, Yun-Gyoo Lee, Keon Uk Park, Ho Jung An, Joohyuk Sohn, Young Mi Seol, Hyunwoo Lee, Hwan-Jung Yun, Jin Seok Ahn, Ji Hyun Yang, Hunho Song, Dong-Hoe Koo, Jin Young Kim, Gun Min Kim, Hwa Jung Kim
Cancer Res Treat.2020;52(3):907-916.   Published online 2020 March 18     DOI: http://dx.doi.org/10.4143/crt.2019.713
      
3 A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study
So-Yeon Jeon, Hye Sook Han, Woo Kyun Bae, Moo-Rim Park, Hyeok Shim, Sang-Cheol Lee, Se-Il Go, Hwan Jung Yun, Yong-Jin Im, Eun-Kee Song
Cancer Res Treat.2019;51(1):90-97.   Published online 2018 February 27     DOI: http://dx.doi.org/10.4143/crt.2017.577
      
4 Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02)
Shunsuke Ohnishi, Hidemichi Watari, Maki Kanno, Yoko Ohba, Satoshi Takeuchi, Tempei Miyaji, Shunsuke Oyamada, Eiji Nomura, Hidenori Kato, Toru Sugiyama, Masahiro Asaka, Noriaki Sakuragi, Takuhiro Yamaguchi, Yasuhito Uezono, Satoru Iwase
J Gynecol Oncol.2017;28(5):e44.  Published online 2017 March 17     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e44
      
5 A Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer Patients
Yusook Jeong, Hye Sook Han, Hyo Duk Lee, Jiyoul Yang, Jiwon Jeong, Moon Ki Choi, Jihyun Kwon, Hyun-Jung Jeon, Tae-Keun Oh, Ki Hyeong Lee, Seung Taik Kim
Cancer Res Treat.2016;48(4):1429-1437.   Published online 2016 February 29     DOI: http://dx.doi.org/10.4143/crt.2015.464
      
6 Clinical Practices and Outcomes on Chemotherapy-Induced Nausea and Vomiting Management in South Korea: Comparison with Asia-Pacific Data of the Pan Australasian Chemotherapy Induced Emesis Burden of Illness Study
Myung Ah Lee, Eun Kyung Cho, Sung Yong Oh, Joong Bae Ahn, Ji Yun Lee, Burke Thomas, Hun Jung, Jong Gwang Kim
Cancer Res Treat.2016;48(4):1420-1428.   Published online 2016 February 12     DOI: http://dx.doi.org/10.4143/crt.2015.309
      
7 Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
Satoe Fujiwara, Yoshito Terai, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Masahide Ohmichi
J Gynecol Oncol.2015;26(4):311-319.   Published online 2015 July 20     DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.311
      
8 Incidence and Risk Factors of Postoperative Nausea and Vomiting in Patients with Fentanyl-Based Intravenous Patient-Controlled Analgesia and Single Antiemetic Prophylaxis
Jong Bum Choi, Yon Hee Shim, Youn-Woo Lee, Jeong Soo Lee, Jong-Rim Choi, Chul Ho Chang
Yonsei Med J.2014;55(5):1430-1435.   Published online 2014 July 18     DOI: http://dx.doi.org/10.3349/ymj.2014.55.5.1430
      
9 Comparative Study of an Ondansetron and a Ramosetron an Aprepitant in the Control of Nausea and Vomiting in Gynecologinc Cancer Patient with Chemotherapy
HANGGOO Yun, Heung Yeol Kim, Eun ae Jeh
Kosin Med J.2013;28(2):115-121.   Published online 2013 January 19     DOI: http://dx.doi.org/10.7180/kmj.2013.28.2.115
   
10 Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis
Won Oak Kim, Bon Nyeo Koo, Yong Kook Kim, Hae Keum Kil
Korean J Anesthesiol.2011;61(5):405-412.   Published online 2011 November 23     DOI: http://dx.doi.org/10.4097/kjae.2011.61.5.405
      
11 Prophylactic antiemetics therapy against gynecologic cancer chemotherapy
Keun Ho Lee, Yong Il Kwon
Korean J Obstet Gynecol.2011;54(3):127-131.   Published online 2011 March 16     DOI: http://dx.doi.org/10.5468/KJOG.2011.54.3.127
      
12 The effectiveness of antiemetics in hyperemesis gravidarum
Byung Chul Hwang, Suk Young Kim
Korean J Obstet Gynecol.2010;53(1):15-22.   Published online 2010 January 31     DOI: http://dx.doi.org/10.5468/kjog.2010.53.1.15
      
13 Acute Dystonia by Droperidol during Intravenous Patient-Controlled Analgesia in Young Patients
Chang Kil Park, Hwan Yeong Choi, In Young Oh, Myung Suk Kim
J Korean Med Sci.2002;17(5):715-717.   Published online 2009 April 23     DOI: http://dx.doi.org/10.3346/jkms.2002.17.5.715
      
14 Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients
Jin-Soo Kim, Ji Yeon Baek, Sook Ryun Park, In Sil Choi, Sang-Il Kim, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim
Cancer Res Treat.2004;36(6):372-376.   Published online 2004 December 31     DOI: http://dx.doi.org/10.4143/crt.2004.36.6.372
      

 1 of 1